For decades, in-out catheterisation was the default method for measuring residual urine volume. That practice has changed. NICE guideline NG123 now recommends portable bladder scanning as the first-line approach — and the clinical evidence behind that recommendation is substantial. This guide sets out the full comparison: when each method is appropriate, what the infection data shows, and how to build a decision framework that reduces unnecessary catheterisation across your facility.
Both catheterisation and bladder scanning serve the same diagnostic purpose: determining how much urine remains in the bladder. The difference lies in how each method achieves that measurement, and what the clinical consequences of that approach are.
Urethral catheterisation — specifically in-out (intermittent) catheterisation — involves inserting a sterile catheter through the urethra into the bladder, draining the urine, measuring the volume, and removing the catheter. The measurement is direct and volumetrically precise. The procedure is invasive, carries a 1–3% infection risk per insertion, causes patient discomfort, and requires sterile technique and trained staff.
Portable bladder scanning uses ultrasound waves emitted from a probe placed on the lower abdomen to calculate bladder volume from the reflected signal. The measurement is non-invasive, takes under one minute, carries no infection risk, and can be performed by a single operator with minimal training. The trade-off is that it measures estimated volume rather than drained volume — though the clinical accuracy is sufficient for the decisions it informs.
The question for clinicians is not which method is more accurate in absolute terms. The question is which method is appropriate for the clinical situation at hand — and for the majority of diagnostic scenarios, the answer has shifted decisively toward bladder scanning.
Catheterisation is not a single procedure — it encompasses four distinct approaches, each with a different clinical indication, infection profile, and relationship to bladder scanning. Understanding these distinctions clarifies where scanning can replace catheterisation and where it cannot.
A single-use catheter is inserted, urine is drained or measured, then the catheter is removed immediately. Used for PVR measurement (now largely replaced by bladder scanning), acute retention relief, and sterile specimen collection.
Infection profile: 1–3% UTI risk per insertion
A Foley catheter with an inflatable balloon is inserted and left in situ for continuous drainage. Used for acute retention management, post-operative monitoring, and long-term bladder management in patients unable to void independently.
Infection profile: 3–7% UTI risk per day in situ
Inserted through the abdominal wall directly into the bladder under local or general anaesthesia. Used when urethral access is contraindicated (urethral trauma, stricture, prostate obstruction) or for long-term management.
Infection profile: Lower UTI risk than IDC; surgical insertion required
Patient-performed intermittent catheterisation for chronic retention or neurogenic bladder. Bladder scanning is used alongside CISC to monitor residual volumes and assess the effectiveness of the self-catheterisation programme.
Infection profile: Lower risk than clinical catheterisation; patient-controlled
Key distinction: Bladder scanning can replace intermittent (in-out) catheterisation for diagnostic PVR measurement in the vast majority of clinical scenarios. It cannot replace indwelling catheterisation, suprapubic catheterisation, or CISC, which serve therapeutic rather than purely diagnostic functions.
The table below compares intermittent catheterisation and portable bladder scanning across twelve clinical and operational attributes. The comparison is specific to the diagnostic use case — measuring bladder volume or post-void residual — which is the scenario where the choice between the two methods is clinically relevant.
| Attribute | Catheterisation | Bladder Scanning |
|---|---|---|
| Invasiveness | Invasive — requires urethral insertion of a flexible tube | Non-invasive — ultrasound probe placed on lower abdomen |
| Infection risk (CAUTI) | 1–3% per procedure; compounds with repeated catheterisations | Zero infection risk — no mucosal contact |
| Measurement accuracy | Gold standard — direct volumetric drainage measurement | ±15% or better; correlation coefficient 0.97–0.99 vs catheter |
| Time per procedure | 5–15 minutes including sterile setup and removal | 30–60 seconds from probe placement to result |
| Staff required | Two staff in most protocols (operator + chaperone/assistant) | Single operator; no chaperone required |
| Patient comfort | Discomfort and pain during insertion; anxiety and embarrassment | Painless; gel applied to abdomen only |
| Consumable cost per use | £3–£8 per catheter pack (sterile, single-use) | Ultrasound gel only — approximately £0.10 per scan |
| Therapeutic capability | Can drain urine therapeutically; suitable for acute retention | Diagnostic only — cannot drain urine |
| Urine specimen collection | Provides sterile specimen for culture and sensitivity | Cannot collect urine specimen |
| Repeat assessment suitability | Each repeat carries infection risk; patient discomfort accumulates | Unlimited repeats with no additional risk or discomfort |
| NICE NG123 recommendation | Not recommended for routine PVR measurement | Recommended as first-line PVR measurement method |
| Training requirement | Competency-based training; clinical skill sign-off required | Short training (30–60 min); most staff competent within one session |
Catheter-associated urinary tract infections (CAUTIs) are the most common healthcare-associated infection in the UK. NHS England data consistently shows that CAUTIs account for approximately 19% of all healthcare-associated infections — a proportion that has remained stubbornly high despite decades of infection control initiatives. The reason is straightforward: every catheter insertion breaches the body's primary defence against ascending infection.
The financial and clinical burden is significant. Each CAUTI episode costs an estimated £1,000–£2,500 in additional treatment, extended length of stay, and staff time. For a 300-bed surgical ward performing 10 in-out catheterisations per day for post-operative monitoring, a 2% infection rate generates approximately 70 preventable CAUTIs per year. Replacing diagnostic catheterisation with bladder scanning eliminates this infection vector at the point of assessment.
The NICE NG123 recommendation to use bladder scanning as the first-line PVR measurement method is, at its core, an infection control recommendation. The guideline acknowledges that catheterisation is more accurate in absolute terms, but concludes that the infection risk of routine diagnostic catheterisation is not clinically justified when a non-invasive alternative of sufficient accuracy exists.
The decision between bladder scanning and catheterisation depends on the clinical scenario, not a blanket preference for one method. The framework below covers the eight most common clinical situations where this decision arises, with a clear recommendation and the clinical rationale behind it.
Bladder scanning confirms volume, but therapeutic drainage is required. Catheterisation is both diagnostic and therapeutic in this scenario.
Bladder scan determines whether the bladder volume warrants catheterisation. If volume < 400 ml, encourage voiding and rescan in 1–2 hours. Catheterise only if volume > 400–500 ml and patient cannot void.
NICE NG123 specifies bladder scanning as the first-line PVR measurement method. Catheterisation is not indicated for diagnostic PVR measurement in the outpatient setting.
Bladder scanning cannot collect a urine specimen. In-out catheterisation provides a sterile mid-stream equivalent when clean-catch specimens are unreliable (e.g., in patients with incontinence or cognitive impairment).
Serial PVR measurement with a bladder scanner tracks treatment response without repeated catheterisation. Each scan takes under one minute and carries no infection risk.
Ultrasound accuracy is reduced by significant abdominal adiposity, post-surgical adhesions, or ascites. In these cases, in-out catheterisation provides a reliable volume measurement.
Routine bladder scanning identifies elevated PVR in residents who are asymptomatic. Catheterisation is not appropriate as a screening tool due to infection risk and patient distress.
After catheter removal, bladder scanning measures the post-void residual to determine whether the TWOC has been successful. A PVR below 150 ml indicates adequate emptying; above 300 ml warrants recatheterisation.
The shift from catheterisation to bladder scanning for diagnostic PVR measurement is not a matter of clinical preference — it is codified in UK national guidelines. Understanding the specific recommendations helps clinical teams justify equipment procurement and standardise practice across their facility.
Transitioning from catheterisation-based PVR measurement to bladder scanning requires a structured implementation approach. The clinical evidence is clear; the practical challenge is standardising the protocol, training staff, and embedding the new practice in ward routines.
NHS trusts that have implemented formal bladder scanning protocols on surgical wards report a 30–50% reduction in post-operative catheterisation rates within the first three months. The key elements of a successful implementation are consistent across published audit reports.
Establish the bladder volume at which catheterisation is indicated. Most surgical ward protocols use 400–500 ml as the threshold for catheterisation in post-operative patients. For chronic retention monitoring, align with NICE NG123 (PVR > 300 ml on two consecutive measurements).
High-throughput surgical wards benefit from a scanner with a large display, rapid scan time, and easy probe positioning. Urology clinics require 3D scanning capability for accurate PVR measurement in patients with irregular bladder anatomy. Care homes need a lightweight, portable device that can be operated by non-specialist staff.
Bladder scanner training takes 30–60 minutes for most staff. The key competencies are probe positioning, patient preparation, interpreting the result display, and documenting the scan. Most manufacturers provide on-site training as part of the device purchase.
The bladder scanning protocol should be integrated into post-operative observation charts, nursing care plans, and electronic patient records. Documenting scan results alongside catheterisation decisions creates an audit trail and supports quality improvement.
Track catheterisation rates, CAUTI incidence, and length of stay before and after protocol implementation. Published NHS audit data consistently shows measurable improvements within 3–6 months of introducing a formal bladder scanning protocol.
Portable bladder scanners achieve a measurement accuracy of ±15% or better in clinical studies, with a correlation coefficient of 0.97–0.99 against catheter-drained volumes in controlled settings. For clinical decision-making — determining whether a patient needs catheterisation — this accuracy is sufficient. NICE NG123 recommends bladder scanning as the first-line method for PVR measurement precisely because the clinical threshold (300 ml) provides a meaningful margin above the measurement error.
Catheterisation is required when the patient cannot void at all (acute urinary retention), when urine must be drained therapeutically (not just measured), when a sterile urine specimen is needed for culture, when the bladder scan is technically difficult due to obesity or post-surgical anatomy, or when the patient requires an indwelling catheter for ongoing management. Bladder scanning replaces catheterisation for diagnostic PVR measurement in all other clinical scenarios.
Each in-out (intermittent) catheterisation carries a 1–3% risk of introducing a urinary tract infection. In patients catheterised repeatedly — such as post-operative monitoring or chronic retention management — this risk compounds with each procedure. NHS England data shows that catheter-associated urinary tract infections (CAUTIs) account for approximately 19% of all healthcare-associated infections, at an estimated cost of £1,000–£2,500 per episode. Replacing diagnostic catheterisation with bladder scanning eliminates this infection vector entirely.
Yes — bladder scanning is the recommended method for monitoring post-operative urinary retention (POUR) on surgical wards. Published NHS audit data shows that bladder scanning protocols reduce unnecessary catheterisation rates by 30–50% compared to symptom-based assessment alone. The standard protocol scans patients every 4–6 hours post-surgery; catheterisation is only performed when the bladder volume exceeds 400–500 ml and the patient is unable to void.
NICE guideline NG123 (Urinary Incontinence and Pelvic Floor Dysfunction, 2019) explicitly recommends portable bladder ultrasound scanning as the first-line method for measuring post-void residual urine. The guideline states that catheterisation should not be used routinely for PVR measurement due to the associated infection risk. BAUS guidelines for LUTS assessment also specify non-invasive bladder scanning as the standard of care.
A portable bladder scan takes 30–60 seconds from probe placement to result display. Urethral catheterisation — including preparation, sterile field setup, insertion, drainage measurement, and removal — takes 5–15 minutes and requires two clinical staff in most protocols. The time saving with bladder scanning is significant on busy surgical wards and in care homes where multiple patients require regular bladder assessment.
"Use portable bladder ultrasound scanning to measure post-void residual urine. Do not use catheterisation routinely to measure post-void residual urine."
NICE NG123, 2019 — Urinary Incontinence and Pelvic Floor Dysfunction
Bladder Scanners UK supplies new, ex-demo, and used portable bladder scanners to NHS trusts, care homes, and private clinics across the UK. Independent advice, competitive pricing, and same-day quotes.